cbdMD (YCBD) Share-based Compensation (2017 - 2025)
cbdMD (YCBD) reported Share-based Compensation of $2505.0 for Q4 2025, down 96.95% on a YoY basis from $82250.0 in Q4 2024, and down 99.85% sequentially from $1.6 million in Q3 2025.
cbdMD (YCBD) Share-based Compensation (2017 - 2025) Analysis & Trends
cbdMD (YCBD) has 9 years of Share-based Compensation data on file, last reported at $2505.0 in Q4 2025.
- For the quarter ending Q4 2025, Share-based Compensation fell 96.95% year-over-year to $2505.0; the trailing twelve-month figure through Dec 2025 stood at $3.3 million (up 2619.53% YoY), and the FY2025 full-year result was $1.7 million, up 4132.15% from the prior year.
- Share-based Compensation eased to $2505.0 in Q4 2025, from $1.6 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.7 million in Q2 2025 to a low of -$709803.0 in Q3 2021.
- A 5-year average of $298988.9 and a median of $52767.0 in 2023 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation tumbled 115.65% in 2021 and jumped 4146.34% in 2025, its largest moves.
- Tracing YCBD's Share-based Compensation over 5 years: stood at $508754.0 in 2021, then slumped by 91.46% to $43449.0 in 2022, then tumbled by 341.9% to -$105101.0 in 2023, then soared by 178.26% to $82250.0 in 2024, then tumbled by 96.95% to $2505.0 in 2025.
- Business Quant data shows YCBD's Share-based Compensation at $2505.0 in Q4 2025, $1.6 million in Q3 2025, and $1.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | 2,505.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,505.00 |
| Dec 31, 2025 | 2,505.00 |
| Sep 30, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Mar 31, 2025 | -79,382.00 |
| Mar 31, 2025 | -79,382.00 |
| Dec 31, 2024 | 82,250.00 |
| Dec 31, 2024 | 82,250.00 |
| Sep 30, 2024 | 38,652.00 |
| Sep 30, 2024 | 38,652.00 |
| Sep 30, 2023 | -105,101.00 |
| Sep 30, 2023 | -105,101.00 |
| Jun 30, 2023 | 8,885.00 |
| Jun 30, 2023 | 8,885.00 |
| Mar 31, 2023 | 52,767.00 |
| Mar 31, 2023 | 52,767.00 |
| Dec 31, 2022 | 43,449.00 |
| Dec 31, 2022 | 43,449.00 |